Live Breaking News & Updates on Hetero group of companies

Stay updated with breaking news from Hetero group of companies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Meet India's richest MP, part of family with Rs 39200 crore wealth, 4th richest pharma tycoon, his net worth is…

Dr B Partha Saradhi Reddy draws his massive wealth from investment and stake in the Hetero Group of Companies which he leads as the Chairman. ....

Bharat-rashtra-samithi , B-partha-saradhi-reddy , Rajya-sabha , Hetero-group-of-companies , Member-of-parliament , Osmania-university-of-hyderabad , Hetero-group , Synthetic-organic-chemistry , Organic-chemistry , Osmania-university , Hurun-india-rich-list , Hyderabad-basedb-partha-saradhi-reddy

Banapuram to Burma, a journey

Former Ambassador High Commissioner G Parthasarathy shared anecdotes from his interactions with the author during their diplomatic service. ....

Hyderabad , Andhra-pradesh , India , Osmania-university , Khammam , Australia , Daspalla , Orissa , Telangana , Justicep-madhavi-devi , Avula-bhaskar-reddy , B-parthasarathi-reddy

Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification

27.12.2022 - Hetero s Nirmacom (Nirmatrelvir), a generic version of Pfizer s COVID-19 oral antiviral drug PAXLOVID is co-packaged with ritonavir tabletsWith the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs . ....

India , Charles-gore , Vamsi-krishna-bandi , Hetero-group-of-companies , Pfizer , Managing-director , Hetero-group , Medicines-patent-pool , Executive-director ,

Hetero's Nirmacom World's 1st Generic Covid Oral Drug Paxlovid to Get WHO Pre-qualification

Hetero, India’s leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral antiviral treatment candidate nirmatrelvir. This is the first prequalification for a generic version of Pfizer’s COVID-19 oral antiviral drug ....

India , Charles-gore , Vamsi-krishna-bandi , Hetero-group-of-companies , Pfizer , World-health-organization-prequalification-of-medicines-program , World-health-organization-prequalification , Medicines-program , Managing-director , Hetero-group , Medicines-patent-pool , Executive-director

Welcome To IANS Live - NATION - Hetero's Covid-19 oral drug gets WHO pre-qualification

This is the first pre-qualification for a generic version of Pfizer s Covid-19 oral antiviral drug Paxlovid , which the WHO called, the best therapeutic choice for high-risk patients to date.WHO ....

Hyderabad , Andhra-pradesh , India , Charles-gore , Vamsi-krishna-bandi , Pfizer , Hetero-group-of-companies , World-health-organization-prequalification-of-medicines-programme , World-health-organization-prequalification , Medicines-programme , Managing-director , Hetero-group